CardioComm Solutions, Inc.

CardioComm Solutions, Inc.

November 09, 2005 12:32 ET

CardioComm Solutions Inc. Recognized as #154 in 2005 Deloitte Technology Fast 500

VICTORIA, BRITISH COLUMBIA--(CCNMatthews - Nov. 9, 2005) - CardioComm Solutions Inc. (TSX VENTURE:CCG) (the "Company", "CardioComm"), is pleased to announce that it has placed #154 in the prestigious 2005 Deloitte Technology Fast 500.

The Technology Fast 500 is a ranking of the 500 fastest growing technology companies in Canada and the United States based on percentage revenue growth over five years from 2000 - 2004.

"Achieving sustained revenue growth of 1,240% over five years is a tremendous achievement," said Tony Kern, deputy national managing principal of Deloitte's Technology, Media & Telecommunications industry practice. "CardioComm Solutions' phenomenal growth puts it in select company."

"It is a honor to be recognized by Deloitte & Touche for outstanding growth and technical achievement," stated Stephen Martin, President and CEO. "Our software development team and dedicated sales force deserve the credit for our growth over the past five years as we strive to improve cardiac information systems."

The Fast 500 list is compiled from Deloitte's 15 regional North American Fast 50 lists. Entrants must be headquartered in North America and must be a "technology company", defined as a company that owns proprietary technology that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology in a unique way does not qualify. Canada has 10 percent of the Fast 500 (53 companies) of this year's winners.

Complete details can be found at

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte", "Deloitte & Touche", "Deloitte Touche Tohmatsu" or other related names.

Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein.

Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP.

About CardioComm Solutions Inc:

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.

On behalf of the Board of Directors of CardioComm Solutions Inc.:

Stephen R. Martin, President & CEO

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release.

Contact Information